Onychomadesis and palmoplantar keratoderma associated with talquetamab therapy for relapsed and refractory multiple myeloma

Neha Narayan; Benjamin Williams; Brea Lipe; Anna De Benedetto

doi:10.1016/j.jdcr.2022.11.013

Onychomadesis and palmoplantar keratoderma associated with talquetamab therapy for relapsed and refractory multiple myeloma

JAAD Case Rep. 2022 Nov 17:31:66-68. doi: 10.1016/j.jdcr.2022.11.013. eCollection 2023 Jan.

Authors

Neha Narayan¹, Benjamin Williams², Brea Lipe³, Anna De Benedetto²

Affiliations

¹ University of Rochester School of Medicine and Dentistry, Rochester, New York.
² Department of Dermatology, University of Rochester Medical Center, Rochester, New York.
³ Department of Hematology and Oncology, University of Rochester Medical Center, Rochester, New York.

No abstract available

Keywords: G-protein-coupled; GPRC5D, G protein-coupled receptor family C group 5-member D; MM, multiple myeloma; R/R, relapsed or refractory; anticancer drugs; bispecific antibody; chemotherapeutic; cytotoxicity; drug effects; immunology; immunotherapy; multiple myeloma; nail diseases; onychomadesis; palmoplantar keratoderma; talquetamab.; targeted therapy.

Publication types

Case Reports